中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2012年
36期
40-41
,共2页
成人流行性腮腺炎%疏肝化瘀颗粒%联合治疗
成人流行性腮腺炎%疏肝化瘀顆粒%聯閤治療
성인류행성시선염%소간화어과립%연합치료
Adult mumps%Sugan huayu granule%Combination therapy
目的探讨疏肝化瘀颗粒联合α-1b 干扰素治疗成人流行性腮腺炎的疗效.方法87例成人流行性腮腺炎2009至2011年住院患者,随机选取46例应用疏肝化瘀颗粒及α-1b 干扰素作为联合治疗组,另外患者41例未用疏肝化瘀颗粒为对照组.观察患者血、尿淀粉酶结果及腮腺、睾丸肿胀情况,发热症状缓解时间.结果和对照组相比较,联合治疗组虽然在缓解发热症状方面没有明显差异(P >0.05),但是在降低血、尿淀粉酶及缓解腮腺肿胀、睾丸炎方面,联合治疗组有着显著差异(P <0.001).结论疏肝化瘀颗粒联合α-1b 干扰素治疗成人流行性腮腺炎的有较好疗效.
目的探討疏肝化瘀顆粒聯閤α-1b 榦擾素治療成人流行性腮腺炎的療效.方法87例成人流行性腮腺炎2009至2011年住院患者,隨機選取46例應用疏肝化瘀顆粒及α-1b 榦擾素作為聯閤治療組,另外患者41例未用疏肝化瘀顆粒為對照組.觀察患者血、尿澱粉酶結果及腮腺、睪汍腫脹情況,髮熱癥狀緩解時間.結果和對照組相比較,聯閤治療組雖然在緩解髮熱癥狀方麵沒有明顯差異(P >0.05),但是在降低血、尿澱粉酶及緩解腮腺腫脹、睪汍炎方麵,聯閤治療組有著顯著差異(P <0.001).結論疏肝化瘀顆粒聯閤α-1b 榦擾素治療成人流行性腮腺炎的有較好療效.
목적탐토소간화어과립연합α-1b 간우소치료성인류행성시선염적료효.방법87례성인류행성시선염2009지2011년주원환자,수궤선취46례응용소간화어과립급α-1b 간우소작위연합치료조,령외환자41례미용소간화어과립위대조조.관찰환자혈、뇨정분매결과급시선、고환종창정황,발열증상완해시간.결과화대조조상비교,연합치료조수연재완해발열증상방면몰유명현차이(P >0.05),단시재강저혈、뇨정분매급완해시선종창、고환염방면,연합치료조유착현저차이(P <0.001).결론소간화어과립연합α-1b 간우소치료성인류행성시선염적유교호료효.
Objective To investigate the efficacy of sugan huayu Granule and Interferon α-1b combination therapy in adult mumps patients. Methods A total of 87 adult mumps patients were enrolled in the study from 2009 to 2011 in Jining city hospital for infectious diseases of Shandong province . They were randomly divided into two groups : 46 cases of adult mumps patients were treated with sugan huayu Granule and Interferon α-1b as the treatment group,41 cases of adult mumps patients were treated without sugan huayu Granule as the control group. The changes of the hemodiastase, urine amylase, swelling of parotid gland and testis, fever time of symptoms,were observed. Results After treatment the fever time of symptoms of the combination therapy group,there were no significant differences compared with the control group(P>0.05).But, all of the hemodiastase, urine amylase, swelling of parotid gland and testis,were significant differences compared with the control group(P<0.001).Conclusion Sugan huayu Granule combined with interferon α-1b treatment showed better therapeutic efficacy on adult mumps patients.